Glonghui, January 11 | Orient (605116.SH) announced that Orient Pharmaceutical (Tianjin) Co., Ltd. (known as “Tianjin Orient”), a wholly-owned subsidiary of the company, recently received the “High-tech Enterprise Certificate” jointly issued by the Tianjin Municipal Bureau of Science and Technology, the Tianjin Municipal Finance Bureau, and the Tianjin Municipal Taxation Bureau of the State Administration of Taxation. Certificate number: GR202312001758, issuance time: December 8, 2023, validity period: three years. This is the first time that Tianjin Orient has been certified as a high-tech enterprise.
奥锐特(605116.SH)：全资子公司通过高新技术企业认定
Orient (605116.SH): Wholly-owned subsidiary approved as a high-tech enterprise
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.